《大行報告》高盛:特斯拉應用軟體近周下載增20% 顯示中國新能源車需求趨升
特斯拉昨晚股價抽升12.6%收419.62美元。高盛發布報告援引《Sensor Tower》數據顯示,特斯拉全球應用軟體下載呈逐年上升趨勢,最近一周的全球數據年增約20%,該行指應用軟體下載趨勢顯示在中國行業增長前景。
由於特斯拉通常在每個季度的最後一個月有更強大的交付量,該行以三個月移動平均值為基礎顯示此數據。高盛維持對特斯拉「中性」投資評級及目標價295美元。
此外,本港上市的新能源汽車股份比亞迪(01211.HK)今日早市股價上揚12.9%收97.5港元。(wl/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.